JPMorgan stock 'hard to ignore' with 2025 ROTCE above target, says UBS
UBS increased their price target for JPMorgan shares, listed on the New York Stock Exchange (NYSE:JPM), to $287 from the ...
JPMorgan Chase & Co. (JPM) Gets a Buy from Piper Sandler
Piper Sandler analyst Scott Siefers maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report) today and set a price target of ...
JPMorgan posts record annual profit as dealmakers, traders ride market rebound
JPMorgan Chase on Wednesday posted record annual profit as its dealmakers and traders reaped a windfall from rebounding ...
Fierce Healthcare1d
JPM25: Teladoc sees virtual chronic condition management as a key growth driver, joins Amazon's health benefits program
Teladoc Health faces pressure in a saturated telehealth market, but it's hard to ignore the virtual care company's massive ...
JPMorgan Chase: Strong Financial Performance and Optimistic Growth Outlook Justify Buy Rating
In a report released today, Glenn Schorr from Evercore ISI maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report), with a ...
Pharmaceutical Technology1d
JP Morgan 2025: Almirall updates strategy with focus on medical dermatology
Spain’s Almirall has announced strategic plans at the 43rd JP Morgan Healthcare Conference based on expected double-digit growth within the dermatological area for Almirall’s psoriasis and atopic ...
Fierce Healthcare1d
JPM25: Checking in with Morgan Health
In 2021, JPMorgan Chase formed Morgan Health from the ashes of Haven, its scuttled healthcare collaboration with Amazon and ...
JPMorgan asks staff to return to office five days a week, prompting complaints
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...